$2.42
0.12[5.22%]
Last update: 11:10AM Get Real Time Here
Esperion Therapeutics
(NASDAQ:ESPR)Esperion Therapeutics Stock (NASDAQ:ESPR), Quotes and News Summary
Esperion Therapeutics Stock (NASDAQ: ESPR) stock price, news, charts, stock research, profile.
| Open | $2.310 |
| Close | - |
| Volume / Avg. | 2.558M / 7.091M |
| Day Range | 2.275 - 2.478 |
| 52 Wk Range | 0.700 - 3.400 |
| Market Cap | $458.494M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 58 |
| Short Interest | 10.51% |
| Days to Cover | 4.07 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Esperion Therapeutics (ESPR) stock?
You can purchase shares of Esperion Therapeutics (NASDAQ: ESPR) through any online brokerage.
Who are Esperion Therapeutics's (ESPR) competitors?
Other companies in Esperion Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
What is the target price for Esperion Therapeutics (ESPR) stock?
The latest price target for Esperion Therapeutics (NASDAQ: ESPR) was reported by HC Wainwright & Co. on Wednesday, May 8, 2024. The analyst firm set a price target for 16.00 expecting ESPR to rise to within 12 months (a possible 561.16% upside). 16 analyst firms have reported ratings in the last year.
Current Stock Price for Esperion Therapeutics (ESPR)?
The stock price for Esperion Therapeutics (NASDAQ: ESPR) is $2.42 last updated Today at May 16, 2024 at 11:10 AM EDT.
Does Esperion Therapeutics (ESPR) pay a dividend?
There are no upcoming dividends for Esperion Therapeutics.
When is Esperion Therapeutics (NASDAQ:ESPR) reporting earnings?
Esperion Therapeutics’s Q2 earnings are confirmed for Tuesday, July 30, 2024.
Is Esperion Therapeutics (ESPR) going to split?
There is no upcoming split for Esperion Therapeutics.
What sector and industry does Esperion Therapeutics (ESPR) operate in?
Esperion Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.